CHICAGO, Oct. 21, 2013 /PRNewswire-USNewswire/ -- Citizens United for Research in Epilepsy (CURE), the leading nongovernmental funder of epilepsy research, is proud to announce the most recent recipients of research grants awarded this year. Over $2 million was awarded in this cycle.
"These investigators have demonstrated they understand the urgency in finding cures for the epilepsies, and we are confident in their abilities to accelerate breakthroughs," stated Susan Axelrod, Founding Chair of CURE.
CURE congratulates the esteemed researchers, listed below.
Multi-year grants up to $250,000 for investigators exploring cutting-edge approaches to curing the epilepsies.
John Huguenard, PhD and Jeanne Paz, PhD (Stanford University)
Janice Naegele, PhD (Wesleyan University)
Prevention of Acquired Epilepsies Awards
Multi-year grants up to $250,000 in support of research into the prevention and treatment of epilepsies that occur after insult to the brain such as traumatic brain injury, stroke, tumor and viral infections.
Detlev Boison, PhD (Legacy Emanuel Hospital and Health Center-Portland, OR)
Amy Brooks-Kayal, MD (University of Colorado Denver) and Shelley Russek, PhD (Boston University School of Medicine)
Raimondo D'Ambrosio, PhD (University of Washington)
Sudden Unexpected Death in Epilepsy (SUDEP) Awards
One-year grants up to $100,000 in support of innovative research that will enhance our understanding and ability to prevent SUDEP.
Gordon Buchanan, MD, PhD (Yale University)
David Paterson, PhD (Boston Children's Hospital)
Else Tolner, PhD and Arn van den Maagdenberg, PhD (Leiden University Medical Center [LUMC] the Netherlands)
Pediatric Epilepsies Awards
Multi-year grants up to $250,000 in support of research projects addressing the many syndromes that affect children.
Edward Cooper, MD, PhD (Baylor College of Medicine)
Timothy Simeone, PhD (Creighton University)
Citizens United for Research in Epilepsy (CURE) is the leading nongovernmental agency fully committed to funding research in the epilepsies. Nearly 90 cents of every dollar goes toward research program activities. Since its inception in 1998, CURE has raised more than $26 million.